This functional depletion of ACE2 could tip the physiological axis toward vasoconstriction, inflammation, and hypertension, highlighting a plausible mechanism through which genetically susceptible individuals may develop post-COVID new-onset hypertension (PCNH). The gene discussed is ACE2; the disease is hypertensive disorder.